206 related articles for article (PubMed ID: 9578778)
1. Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
Bennett PF; Norman EJ
Aust Vet J; 1998 Feb; 76(2):101-3. PubMed ID: 9578778
[TBL] [Abstract][Full Text] [Related]
2. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
3. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
Feldman EC
J Am Vet Med Assoc; 1986 Dec; 189(12):1562-6. PubMed ID: 3025143
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane.
Peterson ME; Kintzer PP
Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):255-72. PubMed ID: 9076906
[TBL] [Abstract][Full Text] [Related]
7. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995).
Greco DS; Peterson ME; Davidson AP; Feldman EC; Komurek K
J Am Vet Med Assoc; 1999 May; 214(9):1349-53. PubMed ID: 10319177
[TBL] [Abstract][Full Text] [Related]
8. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
Reine NJ
Clin Tech Small Anim Pract; 2007 Feb; 22(1):18-25. PubMed ID: 17542193
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma and hyperadrenocorticism in dogs: six cases (1982-1992).
von Dehn BJ; Nelson RW; Feldman EC; Griffey SM
J Am Vet Med Assoc; 1995 Aug; 207(3):322-4. PubMed ID: 7628933
[TBL] [Abstract][Full Text] [Related]
10. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
Nelson RW; Feldman EC; Shinsako J
Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
[TBL] [Abstract][Full Text] [Related]
11. Mitotane (o,p'-DDD) treatment in a cat with hyperadrenocorticism.
Schwedes CS
J Small Anim Pract; 1997 Nov; 38(11):520-4. PubMed ID: 9403812
[TBL] [Abstract][Full Text] [Related]
12. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism.
Rijnberk A; Belshaw BE
Vet Rec; 1988 May; 122(20):486-8. PubMed ID: 3420770
[TBL] [Abstract][Full Text] [Related]
13. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
Angles JM; Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
[TBL] [Abstract][Full Text] [Related]
14. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
Ford SL; Feldman EC; Nelson RW
J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
[TBL] [Abstract][Full Text] [Related]
15. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism.
Dunn KJ; Herrtage ME; Dunn JK
Vet Rec; 1995 Aug; 137(7):161-5. PubMed ID: 8553523
[TBL] [Abstract][Full Text] [Related]
16. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia.
Norman EJ; Thompson H; Mooney CT
Vet Rec; 1999 May; 144(20):551-4. PubMed ID: 10371012
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
Behrend EN; Kemppainen RJ; Clark TP; Salman MD; Peterson ME
J Am Vet Med Assoc; 1999 Oct; 215(7):938-43. PubMed ID: 10511856
[No Abstract] [Full Text] [Related]
18. Functioning adrenocortical tumour in a dog.
Vince ME; Watson AD
Aust Vet J; 1982 Apr; 58(4):156-8. PubMed ID: 6289791
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism.
Barker EN; Campbell S; Tebb AJ; Neiger R; Herrtage ME; Reid SW; Ramsey IK
J Vet Intern Med; 2005; 19(6):810-5. PubMed ID: 16355673
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.
Park SM; Kim KB; Song WJ; Youn HY
Vet Med Sci; 2021 Jul; 7(4):1150-1153. PubMed ID: 33755348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
